Biosignatures diagnostic development projects all follow a start in the clinic, finish in the clinic philosophy.
Because so many discovery projects fail when the results are trialled in the clinic, Biosignatures developed discovery technologies capable of being applied to clinical data from the outset.
This means we can (and do) find out if the diagnostic signatures discovered are likely to make it into clinical use very early in the discovery process, avoiding expensive failures.
We are currently working on 2 studies:
We are also getting ready to start on projects in breast cancer, ovarian cancer and neurodegenerative AD/PD.
Please contact us to find out more.